Seroprevalence for measles among healthcare workers in Madrid, Spain

Immunity of healthcare workers (HCWs) against measles is a particular concern. They are more likely to contract it than the general population due to their occupational exposure which may cause a nosocomial outbreak. To assess the measles immune status of HCWs at five Spanish university hospitals. S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of hospital infection 2024-05, Vol.147, p.63-67
Hauptverfasser: Cuerda, A.de la, González, M.I.Tejeda, López Aparicio, A., Monfort Vinuesa, C., López Pedraza, M.J., Isidoro, B., Mayordomo-Cava, J., Barberán, L.C., Collazos, J., Pérez-Ortiz, J.M., Barberán, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immunity of healthcare workers (HCWs) against measles is a particular concern. They are more likely to contract it than the general population due to their occupational exposure which may cause a nosocomial outbreak. To assess the measles immune status of HCWs at five Spanish university hospitals. Serologic testing (IgG) for measles by chemiluminescence indirect immunoassay (CLIA) was carried out prospectively and consecutively in HCWs from five university hospitals. All HCWs were classified into four epidemiological groups: vaccinated individuals, those with a history of measles disease, subjects with no history of measles or vaccination, and those who did not know whether they had measles or were vaccinated, and into five professional categories: physicians, nurses, nursing assistants, other clinical workers and non-clinical workers. A logistic regression model was constructed to identify the factors independently associated with immunity to measles. The study group was composed of 2157 HCWs. 89% had protective antibodies against measles. Of the 238 non-immune HCWs, 199 (83.6%) had been vaccinated, compared with 1084 of the 1919 (56.5%) immune individuals (P
ISSN:0195-6701
1532-2939
DOI:10.1016/j.jhin.2023.11.006